Event Date: May 12, 2020
The presentation focuses on medical oncology (surgery and devices out of scope) and covers:
- Brief overview on treatment evolution
- Remaining issues of side effects of immunotherapies
- Clinician perspective on endpoints (e.g. statistically significant does not mean clinically meaningful)
- PRO and patients perspectives, evolving health authorities perspective
- Biomarkers
The speaker uses different examples of oncology trials during the presentation.
Presenter:
- Professor Martin Fey, Medical Oncologist
Click here for additional information and registration details.
